JPRN-UMIN000041754已完成未知
Predictors of abatacept efficacy in immunomics - PREDICTABA study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients treated with more than 3 types of biologics previously Patients with a history of hypersensitivity to any of the ingredients of the abatacept product Patients with a concurrent condition secondary to malignancy Patients with active infection Patients who are pregnant or breastfeeding, or those wishing pregnancy, childbearing, or breastfeeding Patients ineligible for study participation in the opinion of the investigator or subinvestigator
研究者
相似试验
招募中
4 期
Can abatacept induce immunological remission under tight control in rheumatoid arthritis patient?Rheumatoid arthritisJPRN-UMIN000005570Department of Rheumatosurgery, Osaka City University Medical School50
招募中
3 期
Abatacept in Immune Checkpoint Inhibitor MyocarditisMyocarditis AcuteCancerNCT05335928Massachusetts General Hospital390
招募中
不适用
Abatacept Research Outcome as a First-line Biological Agent in the Real WorldRheumatoid ArthritisJPRN-UMIN000004651Division of Rheumatology Department of Internal Medicine, Hyogo College of Medicine100
尚未招募
Unknown
Biomarker Screening for Immunotherapy Response Evaluation using Microneedle Patch in Patients with Allergic RhinitisDiseases of the respiratory systemKCT0008534Yonsei University Health System, Severance Hospital30
进行中（未招募）
不适用
Evaluation of Belatacept as First-line Immunosuppression in De Novo Liver Transplant Recipients Revised Protocol Number 04, incorporating Amendments 02, 03, 04 and 05 (version 10.0 dated 20-Nov-09)+ Pharmacogenetics Blood Sample Amendment Number 01 - Site Specific, version 2.0 dated 20-Jul-07First time recipient of a deceased donor liver transplantMedDRA version: 9.1Level: LLTClassification code 10062016Term: ImmunosuppressionMedDRA version: 9.1Level: LLTClassification code 10024714Term: Liver transplantEUCTR2007-002125-68-DEBristol-Myers Squibb International Corporation275